Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2178

TDMS Study 05144-01 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                           SAFFLOWER OIL


NTP Experiment-Test: 05144-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/17/94
Route: GAVAGE                                                                                                     Time: 19:47:02




       Facility:  TSI Mason Research

       Chemical CAS #:  8001-23-8

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60           60                                     
  Scheduled Sacrifice                                 10           10           10            9                                     
  Early Deaths                                                                                                                      
    Natural Death                                      8            8            3           10                                     
    Moribund Sacrifice                                12            9            7            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                30           33           40           36                                     
  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (56)         (59)         (58)         (58)                                   
      Ulcer                                            1 (2%)                                                                       
   Intestine Large, Rectum                            (57)         (57)         (57)         (56)                                   
      Submucosa, Edema                                                                        1 (2%)                                
   Intestine Small, Duodenum                          (58)         (60)         (58)         (58)                                   
      Mucosa, Hyperplasia, Diffuse                     1 (2%)                                                                       
   Intestine Small, Jejunum                           (55)         (58)         (57)         (55)                                   
      Mucosa, Hyperplasia, Diffuse                     1 (2%)                                                                       
   Intestine Small, Ileum                             (55)         (59)         (58)         (56)                                   
      Fibrosis                                                      1 (2%)                                                          
      Inflammation, Chronic Active                                                            1 (2%)                                
      Ulcer                                                                      1 (2%)                                             
   Liver                                              (60)         (60)         (60)         (60)                                   
      Basophilic Focus                                36 (60%)     34 (57%)     41 (68%)     42 (70%)                               
      Clear Cell Focus                                23 (38%)     22 (37%)     25 (42%)     35 (58%)                               
      Cyst                                             2 (3%)                                                                       
      Eosinophilic Focus                               5 (8%)       2 (3%)       4 (7%)       2 (3%)                                
      Fatty Change, Diffuse                                                      1 (2%)       6 (10%)                               
      Fatty Change, Focal                              7 (12%)      4 (7%)       7 (12%)     10 (17%)                               
      Hepatodiaphragmatic Nodule                       4 (7%)       3 (5%)       2 (3%)       2 (3%)                                
      Hepatodiaphragmatic Nodule, Multiple                          1 (2%)                                                          
      Hyperplasia                                      4 (7%)       1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia, Focal                               1 (2%)                                                                       
      Mixed Cell Focus                                 1 (2%)       2 (3%)       2 (3%)       6 (10%)                               
      Necrosis                                         4 (7%)       4 (7%)       4 (7%)       4 (7%)                                
      Pigmentation                                                  1 (2%)                                                          
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
      Thrombosis                                       3 (5%)                                                                       
      Centrilobular, Degeneration                                   1 (2%)                                                          
   Mesentery                                          (10)         (8)          (11)         (7)                                    
      Abscess                                                                    1 (9%)                                             
      Inflammation, Chronic Active                                  1 (13%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Artery, Inflammation, Chronic Active                                       1 (9%)                                             
      Fat, Hemorrhage                                               1 (13%)                                                         
      Fat, Inflammation, Chronic Active                2 (20%)                                1 (14%)                               
      Fat, Mineralization                              1 (10%)      1 (13%)                                                         
      Fat, Necrosis                                    8 (80%)      5 (63%)      9 (82%)      6 (86%)                               
   Pancreas                                           (60)         (60)         (59)         (59)                                   
      Acinus, Atrophy                                 48 (80%)     45 (75%)     41 (69%)     43 (73%)                               
      Acinus, Fibrosis                                 1 (2%)                                                                       
      Acinus, Hyperplasia                             10 (17%)     15 (25%)     33 (56%)     37 (63%)                               
      Artery, Inflammation, Chronic Active             1 (2%)       3 (5%)       1 (2%)       1 (2%)                                
      Vein, Angiectasis                                1 (2%)                                                                       
   Salivary Glands                                    (60)         (59)         (60)         (60)                                   
      Hyperplasia                                                   2 (3%)                                                          
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Duct, Metaplasia                                 1 (2%)                                                                       
      Duct, Metaplasia, Squamous                      14 (23%)     11 (19%)     10 (17%)     13 (22%)                               
   Stomach, Forestomach                               (60)         (60)         (60)         (60)                                   
      Hyperkeratosis                                  11 (18%)     17 (28%)     20 (33%)     24 (40%)                               
      Hyperplasia, Basal Cell                         21 (35%)     17 (28%)     26 (43%)     29 (48%)                               
      Inflammation, Chronic                                                      1 (2%)                                             
      Ulcer                                            3 (5%)       2 (3%)       2 (3%)       4 (7%)                                
   Stomach, Glandular                                 (59)         (60)         (59)         (59)                                   
      Erosion                                          8 (14%)      6 (10%)      1 (2%)       2 (3%)                                
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Metaplasia, Squamous                                                       1 (2%)                                             
      Mineralization                                                                          1 (2%)                                
      Mucosa, Hyperplasia, Diffuse                                  1 (2%)                                                          
   Tongue                                             (1)                                    (1)                                    
      Hyperkeratosis                                                                          1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (60)         (60)                                   
      Cardiomyopathy                                  56 (93%)     56 (93%)     49 (82%)     51 (85%)                               
      Inflammation, Chronic                                                                   1 (2%)                                
      Mineralization                                                1 (2%)                                                          
      Thrombosis                                       2 (3%)       3 (5%)                    1 (2%)                                
      Atrium, Dilatation                                            1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (59)         (60)         (58)                                   
      Hyperplasia                                      1 (2%)       1 (2%)       4 (7%)                                             
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Metaplasia, Osseous                              1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Thrombosis                                       1 (2%)                                                                       
   Adrenal Medulla                                    (59)         (58)         (59)         (58)                                   
      Hyperplasia                                     23 (39%)     24 (41%)     16 (27%)     19 (33%)                               
   Islets, Pancreatic                                 (59)         (60)         (59)         (58)                                   
      Hyperplasia                                      5 (8%)       4 (7%)       4 (7%)       5 (9%)                                
   Parathyroid Gland                                  (55)         (50)         (50)         (51)                                   
      Hyperplasia                                      2 (4%)                                 1 (2%)                                
   Pituitary Gland                                    (60)         (58)         (59)         (59)                                   
      Congestion                                                                              1 (2%)                                
      Pars Distalis, Angiectasis                       4 (7%)       6 (10%)      3 (5%)       5 (8%)                                
      Pars Distalis, Cyst                              2 (3%)       8 (14%)      1 (2%)       2 (3%)                                
      Pars Distalis, Hyperplasia                       9 (15%)     16 (28%)     11 (19%)     10 (17%)                               
      Pars Intermedia, Angiectasis                                  1 (2%)                                                          
      Pars Nervosa, Cyst                               1 (2%)                                                                       
   Thyroid Gland                                      (58)         (59)         (58)         (58)                                   
      C-Cell, Hyperplasia                             10 (17%)      6 (10%)      9 (16%)     19 (33%)                               
      Follicle, Cyst                                   1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)          (1)          (1)                                                 
      Abdominal, Ectopic Tissue                                     1 (100%)                                                        
      Oral, Hyperplasia, Squamous                                                1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (60)         (60)         (59)         (58)                                   
      Abscess                                          5 (8%)       6 (10%)      4 (7%)       5 (9%)                                
      Cyst                                             3 (5%)       2 (3%)       1 (2%)       1 (2%)                                
      Dilatation                                       8 (13%)                   2 (3%)                                             
      Dilatation, Multiple                             1 (2%)                                                                       
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Inflammation, Chronic Active                                                            1 (2%)                                
   Prostate                                           (59)         (59)         (58)         (58)                                   
      Hyperplasia                                      1 (2%)       5 (8%)       2 (3%)       3 (5%)                                
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic                                         1 (2%)                                                          
      Metaplasia, Squamous                             2 (3%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Interstitium, Edema                              1 (2%)                                                                       
   Seminal Vesicle                                    (60)         (59)         (60)         (59)                                   
      Depletion Cellular                              18 (30%)                                                                      
   Testes                                             (60)         (60)         (59)         (60)                                   
      Interstitial Cell, Hyperplasia                   8 (13%)     11 (18%)      6 (10%)     11 (18%)                               
      Seminiferous Tubule, Atrophy                     3 (5%)       3 (5%)       1 (2%)       2 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (25)         (19)         (18)         (8)                                    
      Inguinal, Infiltration Cellular, Plasma Cell                               1 (6%)                                             
      Mediastinal, Angiectasis                         2 (8%)       1 (5%)       3 (17%)      3 (38%)                               
      Mediastinal, Ectasia                                          1 (5%)                                                          
      Mediastinal, Hematopoietic Cell Proliferation    1 (4%)                                                                       
      Mediastinal, Hemorrhage                          1 (4%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid                                         1 (6%)                                             
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                                                   1 (6%)                                             
      Mediastinal, Infiltration Cellular,                                                                                           
          Polymorphonuclear                                                      1 (6%)                                             
      Mediastinal, Inflammation, Acute                              1 (5%)                                                          
      Mediastinal, Pigmentation                        2 (8%)       5 (26%)                                                         
      Mediastinal, Lymphatic, Ectasia                  1 (4%)                                                                       
      Pancreatic, Angiectasis                                       1 (5%)                    1 (13%)                               
      Pancreatic, Hyperplasia, Lymphoid                3 (12%)      1 (5%)       3 (17%)                                            
      Pancreatic, Infiltration Cellular, Histiocyte    1 (4%)       1 (5%)                                                          
      Pancreatic, Pigmentation                         1 (4%)                                                                       
      Renal, Angiectasis                               1 (4%)                                                                       
      Renal, Infiltration Cellular, Histiocyte         1 (4%)                                                                       
   Lymph Node, Mandibular                             (60)         (56)         (57)         (59)                                   
      Angiectasis                                                   4 (7%)                                                          
      Congestion                                                                              1 (2%)                                
      Ectasia                                                       2 (4%)       1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                                         1 (2%)                    1 (2%)                                
      Infiltration Cellular, Plasma Cell               3 (5%)                                                                       
      Inflammation, Acute                                           1 (2%)                                                          
      Pigmentation                                                  2 (4%)                                                          
      Lymphatic, Ectasia                                            1 (2%)                    1 (2%)                                
   Lymph Node, Mesenteric                             (59)         (60)         (59)         (58)                                   
      Angiectasis                                      1 (2%)       3 (5%)       2 (3%)                                             
      Congestion                                                                              1 (2%)                                
      Ectasia                                                                    1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                                 1 (2%)                                
      Inflammation, Acute                              1 (2%)                                                                       
      Pigmentation                                                  1 (2%)                                                          
   Spleen                                             (60)         (60)         (58)         (60)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Angiectasis                                                   1 (2%)                                                          
      Atrophy                                          1 (2%)                                                                       
      Depletion Lymphoid                               2 (3%)                    1 (2%)       1 (2%)                                
      Developmental Malformation                                                              1 (2%)                                
      Fibrosis                                        14 (23%)      4 (7%)                                                          
      Hematocyst                                                                              1 (2%)                                
      Hematopoietic Cell Proliferation                 2 (3%)       8 (13%)      6 (10%)      6 (10%)                               
      Infarct                                          3 (5%)                    3 (5%)                                             
      Pigmentation                                     1 (2%)      13 (22%)                   2 (3%)                                
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
      Lymphoid Follicle, Atrophy                                                              1 (2%)                                
   Thymus                                             (50)         (51)         (51)         (52)                                   
      Depletion Lymphoid                               1 (2%)                                                                       
      Hemorrhage                                                                 1 (2%)                                             
      Epithelial Cell, Hyperplasia                                                            1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (52)         (53)         (51)                                   
      Galactocele                                                   2 (4%)                    1 (2%)                                
   Skin                                               (58)         (59)         (60)         (60)                                   
      Cyst Epithelial Inclusion                        2 (3%)       2 (3%)                                                          
      Erosion                                                                    1 (2%)                                             
      Hyperkeratosis                                   1 (2%)                                 1 (2%)                                
      Hyperplasia, Basal Cell                          1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Foot, Acanthosis                                                                        1 (2%)                                
      Foot, Inflammation, Chronic Active                                                      1 (2%)                                
      Subcutaneous Tissue, Granuloma                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (50)         (50)         (50)         (51)                                   
      Fibrosis                                         1 (2%)       1 (2%)                                                          
      Inflammation, Acute                                                                     1 (2%)                                
      Abdominal, Fibrosis                              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)         (60)                                   
      Congestion                                       1 (2%)                                 1 (2%)                                
      Hemorrhage                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (59)                                   
      Congestion                                       2 (3%)       2 (3%)       2 (3%)       2 (3%)                                
      Edema                                                         1 (2%)                    1 (2%)                                
      Fibrosis                                         1 (2%)                    1 (2%)                                             
      Hemorrhage                                       2 (3%)       1 (2%)       2 (3%)                                             
      Hemorrhage, Focal                                             1 (2%)                                                          
      Infiltration Cellular, Histiocyte                4 (7%)      11 (18%)      5 (8%)                                             
      Inflammation, Acute                              1 (2%)                    1 (2%)       1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 4 (7%)       2 (3%)       3 (5%)       3 (5%)                                
      Alveolus, Foreign Body                                        1 (2%)                                                          
      Alveolus, Infiltration Cellular, Histiocyte      1 (2%)       1 (2%)                                                          
      Alveolus, Inflammation, Acute                    1 (2%)                                                                       
      Alveolus, Pigmentation, Focal                    1 (2%)                                                                       
      Bronchiole, Metaplasia, Squamous                                           1 (2%)                                             
      Interstitium, Inflammation, Chronic Active                    1 (2%)                                                          
      Mediastinum, Abscess                                                                    1 (2%)                                
   Nose                                               (60)         (60)         (60)         (60)                                   
      Foreign Body                                     7 (12%)     50 (83%)     48 (80%)     51 (85%)                               
      Fungus                                          24 (40%)     46 (77%)     41 (68%)     41 (68%)                               
      Hyperkeratosis                                   1 (2%)                                                                       
      Inflammation, Acute                             26 (43%)     59 (98%)     60 (100%)    59 (98%)                               
      Metaplasia, Squamous                             1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Acute           1 (2%)                                                                       
      Respiratory Epithelium, Hyperplasia             13 (22%)     48 (80%)     56 (93%)     53 (88%)                               
      Respiratory Epithelium, Metaplasia, Squamous    16 (27%)     39 (65%)     34 (57%)     29 (48%)                               
      Vein, Thrombosis                                 1 (2%)                                                                       
   Trachea                                            (59)         (60)         (60)         (59)                                   
      Lumen, Thrombosis                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (1)          (2)          (1)          (1)                                    
      Inflammation, Chronic Active                                               1 (100%)     1 (100%)                              
   Eye                                                (2)                                    (2)                                    
      Inflammation, Chronic Active                                                            1 (50%)                               
      Cornea, Necrosis                                 1 (50%)                                                                      
      Lens, Cataract                                   1 (50%)                                1 (50%)                               
      Retina, Atrophy                                                                         1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05144-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           SAFFLOWER OIL                                       Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 19:47:02  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (58)                                   
      Cyst                                             2 (3%)                    3 (5%)                                             
      Degeneration, Hyaline                                         1 (2%)                                                          
      Glomerulosclerosis                               1 (2%)                                                                       
      Nephropathy                                     59 (98%)     56 (93%)     50 (83%)     55 (95%)                               
      Pigmentation                                     5 (8%)                                                                       
      Renal Tubule, Degeneration                       1 (2%)                                                                       
   Urinary Bladder                                    (58)         (59)         (59)         (57)                                   
      Calculus Gross Observation                                    4 (7%)       3 (5%)       3 (5%)                                
      Calculus Micro Observation Only                               4 (7%)       2 (3%)       3 (5%)                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------